FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment
The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...
One in four urged to be wary of certain flu medication - check if you're affected
Many people use over-the-counter remedies to ease flu symptoms, but people with a common health condition should take care ...
IFLScience1h
FDA Approves First-Ever Standalone Therapy For Treatment-Resistant Depression
A nasal spray therapy for treatment-resistant major depressive disorder (MDD) has now been approved by the Food and Drug Administration (FDA) for use on its own, making it the first-ever approved ...
Expert says flu medicine could be harmful if you have condition that affects 1 in 4
The expert continued: " If your blood pressure is within a healthy range and you have no heart-related concerns, short-term use of decongestants as directed is generally safe. However, for individuals ...
Emergent seeking to reverse fortunes and become a major overdose treatment player
Papa presented the company’s “turnaround plan” for 2025 at J.P. Morgan. “We are focused on first stabilising the company, ...
upnorthlive3h
Munson Healthcare adds 25 Narcan distribution boxes in northern Michigan
Munson Healthcare is taking steps to make sure Narcan is accessible to everyone.It's partnering with Harm Reduction Michigan ...
Polyrizon Commences GMP Manufacturing Preliminary Process for its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial
Eurofins CDMO Amatsiaquitaine S.A.S., the GMP manufacturer, to support Polyrizon in future commercialization efforts Raanana, Israel, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (the "Company" or ...
4 Ways To Avoid Employee Retaliation When Coworkers Call In Sick
With flu season nearing its peak, many teams are short-staffed. Here are tips for creating a collaborative team climate where ...
Burrell buys former Rainbow House to use as intensive residential treatment center
The first Burrell clients are expected to move into the former Rainbow House by late spring for intensive treatment of ...
Too Old to Operate10h
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major ...